✦ LIBER ✦

Regulatory review intervals for ophthalmic new drug applications at the US Food and Drug Administration

✍ Scribed by Gary D. Novack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Update on regulatory review intervals fo

✍ Gary D Novack 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Comprehensive Biotechnology || Regulator

✍ Lee, K. 📂 Article 📅 2011 🏛 Elsevier ⚖ 272 KB

A brave new beef: The US food and drug a

✍ Louis M. Solomon; Rebekka C. Noll; David S. Mordkoff; Patrick Murphy; Marcy Role 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Renal risks of sodium phosphate tablets

✍ E. D. Ehrenpreis; D. Parakkal; R. Semer; H. Du 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

US Food and Drug Administration Approval

✍ D'Amico, A. V. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 57 KB

What Is the Value of a Food and Drug Adm

✍ Hecht, Gail A.; Blaser, Martin J.; Gordon, Jeffrey; Kaplan, Lee M.; Knight, Rob; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 89 KB